Company Rating: Superkind Pharma Private Limited
- Establishment & Size: Incorporated on 20 March 2024, Superkind Pharma is a newly founded Indian private limited company based in Gautam Buddha Nagar, Uttar Pradesh. It has a modest authorized and paid‑up capital of ₹100 ,000—indicating a small startup phase reddit.com+13thecompanycheck.com+13company.vakilsearch.com+13.
- Leadership: The board currently consists of two directors—Shahrukh Khan and Mohd Akram—who have been in their roles since its incorporation thecompanycheck.com+1company.vakilsearch.com+1.
- Operational Status: The company is active, unlisted, with no reported regulatory charges or filings beyond its initial registration .
⭐ Rating Summary
| Category | Evaluation |
|---|---|
| Growth Potential | High — Early-stage foundation, room to expand. |
| Financial Strength | Low — Minimal capital, limited financial backing. |
| Transparency | Moderate — Basic MCA details available; no deeper financials reported. |
| Leadership | Neutral — Two named directors; background details unclear publicly. |
| Credibility | Cautious — No operational history or market presence to assess yet. |
| Overall Grade | 2.5 / 5 (Tentative) — Promising start, but mostly unknown so far. |
📌 Notes & Recommendations
- As of now, Superkind Pharma is in its initial setup phase, so considerations like product portfolio, R&D, market reach, and financial performance remain undetermined.
- The authorised/paid-up capital is only ₹100,000, implying limited scale and capitalization.
-
If you're evaluating them as a partner, vendor, or investor, it’s crucial to verify:
- Any pipeline products or active filings.
- Additional funding rounds or paid-up capital increases.
- Quality certifications (e.g., WHO-GMP, ISO).
- Leadership team’s professional track record and industry experience.
🔍 In summary: Superkind Pharma is a fledgling pharma startup with official registration and active status but lacking public data on operations, products, or revenue. Its rating reflects great potential but currently considerable uncertainty.